annual EBITDA:
$1.41B+$541.76M(+62.62%)Summary
- As of today (May 21, 2025), GMAB annual EBITDA is $1.41 billion, with the most recent change of +$541.76 million (+62.62%) on December 31, 2024.
- During the last 3 years, GMAB annual EBITDA has risen by +$741.96 million (+111.58%).
- GMAB annual EBITDA is now at all-time high.
Performance
GMAB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$37.36M-$501.47M(-93.07%)Summary
- As of today (May 21, 2025), GMAB quarterly EBITDA is $37.36 million, with the most recent change of -$501.47 million (-93.07%) on March 1, 2025.
- Over the past year, GMAB quarterly EBITDA has dropped by -$1.38 million (-3.57%).
- GMAB quarterly EBITDA is now -94.43% below its all-time high of $670.32 million, reached on June 30, 2020.
Performance
GMAB quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.18B-$1.38M(-0.12%)Summary
- As of today (May 21, 2025), GMAB TTM EBITDA is $1.18 billion, with the most recent change of -$1.38 million (-0.12%) on March 1, 2025.
- Over the past year, GMAB TTM EBITDA has increased by +$333.06 million (+39.17%).
- GMAB TTM EBITDA is now -3.89% below its all-time high of $1.23 billion, reached on September 30, 2020.
Performance
GMAB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GMAB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.6% | -3.6% | +39.2% |
| 3 y3 years | +111.6% | -59.8% | +112.7% |
| 5 y5 years | +212.3% | -28.9% | +149.9% |
GMAB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.6% | -93.1% | at low | -0.1% | +112.7% |
| 5 y | 5-year | at high | +212.3% | -94.4% | at low | -3.9% | +149.9% |
| alltime | all time | at high | +1482.9% | -94.4% | +233.3% | -3.9% | +2282.7% |
GMAB EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $37.36M(-93.1%) | $1.18B(-0.1%) |
| Dec 2024 | $1.41B(+62.6%) | $538.83M(+97.7%) | $1.18B(+47.6%) |
| Sep 2024 | - | $272.49M(-18.6%) | $802.70M(-14.0%) |
| Jun 2024 | - | $334.73M(+763.9%) | $933.85M(+9.8%) |
| Mar 2024 | - | $38.74M(-75.3%) | $850.35M(-0.1%) |
| Dec 2023 | $865.17M(-16.7%) | $156.73M(-61.2%) | $850.84M(+9.7%) |
| Sep 2023 | - | $403.64M(+60.7%) | $775.90M(-4.9%) |
| Jun 2023 | - | $251.24M(+540.5%) | $816.05M(-11.5%) |
| Mar 2023 | - | $39.23M(-52.0%) | $921.99M(-5.5%) |
| Dec 2022 | $1.04B(+56.2%) | $81.79M(-81.6%) | $975.69M(-5.5%) |
| Sep 2022 | - | $443.79M(+24.2%) | $1.03B(+33.2%) |
| Jun 2022 | - | $357.18M(+284.4%) | $775.44M(+39.4%) |
| Mar 2022 | - | $92.92M(-33.2%) | $556.33M(-19.9%) |
| Dec 2021 | $664.97M(-29.7%) | $139.05M(-25.4%) | $694.73M(+7.8%) |
| Sep 2021 | - | $186.28M(+34.9%) | $644.43M(-4.8%) |
| Jun 2021 | - | $138.08M(-40.3%) | $676.66M(-44.0%) |
| Mar 2021 | - | $231.33M(+160.7%) | $1.21B(+17.4%) |
| Dec 2020 | $945.83M(+109.9%) | $88.74M(-59.4%) | $1.03B(-16.3%) |
| Sep 2020 | - | $218.52M(-67.4%) | $1.23B(+10.1%) |
| Jun 2020 | - | $670.32M(+1175.4%) | $1.12B(+136.1%) |
| Mar 2020 | - | $52.56M(-81.9%) | $473.57M(+8.7%) |
| Dec 2019 | $450.58M(+67.3%) | $289.97M(+175.3%) | $435.62M(+63.5%) |
| Sep 2019 | - | $105.32M(+309.4%) | $266.46M(+38.5%) |
| Jun 2019 | - | $25.73M(+76.1%) | $192.36M(+2.2%) |
| Mar 2019 | - | $14.61M(-87.9%) | $188.27M(-12.8%) |
| Dec 2018 | $269.29M(+55.7%) | $120.80M(+287.0%) | $215.84M(+8.1%) |
| Sep 2018 | - | $31.22M(+44.3%) | $199.66M(+12.4%) |
| Jun 2018 | - | $21.64M(-48.7%) | $177.66M(-24.5%) |
| Mar 2018 | - | $42.18M(-59.7%) | $235.34M(+20.0%) |
| Dec 2017 | $172.92M(-0.7%) | $104.63M(+1035.6%) | $196.10M(-4.5%) |
| Sep 2017 | - | $9.21M(-88.4%) | $205.25M(-8.4%) |
| Jun 2017 | - | $79.31M(+2587.9%) | $224.05M(+34.8%) |
| Mar 2017 | - | $2.95M(-97.4%) | $166.26M(+0.3%) |
| Dec 2016 | $174.11M | $113.77M(+306.1%) | $165.72M(+49.3%) |
| Sep 2016 | - | $28.02M(+30.2%) | $111.00M(+6.5%) |
| Jun 2016 | - | $21.52M(+791.0%) | $104.23M(+17.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $2.42M(-95.9%) | $88.54M(-21.2%) |
| Dec 2015 | $117.45M(+109.9%) | $59.04M(+177.9%) | $112.32M(+75.1%) |
| Sep 2015 | - | $21.25M(+264.1%) | $64.13M(-5.2%) |
| Jun 2015 | - | $5.84M(-77.7%) | $67.65M(+20.8%) |
| Mar 2015 | - | $26.19M(+141.4%) | $55.99M(+15.9%) |
| Dec 2014 | $55.96M(+290.9%) | $10.85M(-56.2%) | $48.30M(+1.4%) |
| Sep 2014 | - | $24.77M(-525.2%) | $47.66M(+100.9%) |
| Jun 2014 | - | -$5.83M(-131.5%) | $23.72M(-10.2%) |
| Mar 2014 | - | $18.50M(+81.3%) | $26.41M(+99.7%) |
| Dec 2013 | $14.31M(-186.1%) | $10.20M(+1121.9%) | $13.23M(>+9900.0%) |
| Sep 2013 | - | $835.10K(-126.7%) | $114.50K(-102.2%) |
| Jun 2013 | - | -$3.13M(-158.9%) | -$5.30M(-38.6%) |
| Mar 2013 | - | $5.32M(-282.9%) | -$8.62M(-64.3%) |
| Dec 2012 | -$16.62M(-53.8%) | -$2.91M(-36.5%) | -$24.15M(-2.2%) |
| Sep 2012 | - | -$4.58M(-29.1%) | -$24.70M(-18.8%) |
| Jun 2012 | - | -$6.45M(-36.8%) | -$30.42M(-15.2%) |
| Mar 2012 | - | -$10.21M(+195.4%) | -$35.88M(-1.0%) |
| Dec 2011 | -$36.01M(+227.5%) | -$3.46M(-66.5%) | -$36.24M(+7.6%) |
| Sep 2011 | - | -$10.30M(-13.5%) | -$33.67M(-620.8%) |
| Jun 2011 | - | -$11.91M(+12.7%) | $6.47M(+93.8%) |
| Mar 2011 | - | -$10.57M(+1090.9%) | $3.34M(-127.1%) |
| Dec 2010 | -$11.00M(-23.8%) | -$887.50K(-103.0%) | -$12.30M(-139.8%) |
| Sep 2010 | - | $29.84M(-298.3%) | $30.92M(-233.0%) |
| Jun 2010 | - | -$15.04M(-42.6%) | -$23.25M(-35.8%) |
| Mar 2010 | - | -$26.21M(-161.9%) | -$36.22M(+204.8%) |
| Dec 2009 | -$14.43M(-85.8%) | $42.33M(-274.0%) | -$11.89M(-78.1%) |
| Sep 2009 | - | -$24.33M(-13.2%) | -$54.22M(+81.4%) |
| Jun 2009 | - | -$28.02M(+1398.6%) | -$29.89M(+1498.6%) |
| Mar 2009 | - | -$1.87M | -$1.87M |
| Dec 2008 | -$101.74M(+74.1%) | - | - |
| Dec 2007 | -$58.43M(-17.3%) | - | - |
| Dec 2006 | -$70.69M(+17.4%) | - | - |
| Dec 2005 | -$60.21M(-167.0%) | - | - |
| Dec 2004 | $89.89M(+24.4%) | - | - |
| Dec 2003 | $72.24M(-9.4%) | - | - |
| Dec 2002 | $79.77M | - | - |
FAQ
- What is Genmab A/S annual EBITDA?
- What is the all time high annual EBITDA for Genmab A/S?
- What is Genmab A/S annual EBITDA year-on-year change?
- What is Genmab A/S quarterly EBITDA?
- What is the all time high quarterly EBITDA for Genmab A/S?
- What is Genmab A/S quarterly EBITDA year-on-year change?
- What is Genmab A/S TTM EBITDA?
- What is the all time high TTM EBITDA for Genmab A/S?
- What is Genmab A/S TTM EBITDA year-on-year change?
What is Genmab A/S annual EBITDA?
The current annual EBITDA of GMAB is $1.41B
What is the all time high annual EBITDA for Genmab A/S?
Genmab A/S all-time high annual EBITDA is $1.41B
What is Genmab A/S annual EBITDA year-on-year change?
Over the past year, GMAB annual EBITDA has changed by +$541.76M (+62.62%)
What is Genmab A/S quarterly EBITDA?
The current quarterly EBITDA of GMAB is $37.36M
What is the all time high quarterly EBITDA for Genmab A/S?
Genmab A/S all-time high quarterly EBITDA is $670.32M
What is Genmab A/S quarterly EBITDA year-on-year change?
Over the past year, GMAB quarterly EBITDA has changed by -$1.38M (-3.57%)
What is Genmab A/S TTM EBITDA?
The current TTM EBITDA of GMAB is $1.18B
What is the all time high TTM EBITDA for Genmab A/S?
Genmab A/S all-time high TTM EBITDA is $1.23B
What is Genmab A/S TTM EBITDA year-on-year change?
Over the past year, GMAB TTM EBITDA has changed by +$333.06M (+39.17%)